Literature DB >> 1876464

Pseudomonas aeruginosa cellulitis and ecthyma gangrenosum in immunocompromised children.

J E Fergie1, C C Patrick, L Lott.   

Abstract

Pseudomonas aeruginosa skin infections are generally considered to be secondary manifestations of disseminated disease. A retrospective analysis of all cases of P. aeruginosa skin infections seen at St. Jude Children's Research Hospital since 1962 revealed 16 episodes of the infection (ecthyma gangrenosum, 8 episodes, 7 patients; cellulitis, 8 episodes, 7 patients) in which blood cultures were uniformly negative for P. aeruginosa. All cases were identified while the patients were receiving ambulatory care. Five episodes developed while the patients' neutrophil counts were greater than 1 x 10(9) cells/liter. Eight patients had acute lymphoblastic leukemia, 2 had acute myeloid leukemia, 2 had aplastic anemia, 1 had transient agranulocytosis and 1 had cyclic neutropenia. There were no solid tumor patients. Although patients received different antibiotic combinations, all had resolutions of their lesions without fatal complications. Patients diagnosed as having cellulitis required a mean of 9.2 days of treatment with intravenous antibiotics, as compared with 17.8 days for those with ecthyma gangrenosum (P less than 0.05 by the Wilcoxon test). These observations show that P. aeruginosa skin infections can develop in the absence of bacteremia in immunocompromised children.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1876464     DOI: 10.1097/00006454-199107000-00003

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

Review 1.  Ecthyma gangrenosum and ecthyma-like lesions: review article.

Authors:  M Vaiman; T Lazarovitch; L Heller; G Lotan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-19       Impact factor: 3.267

2.  Disseminated invasive infection due to Metarrhizium anisopliae in an immunocompromised child.

Authors:  D Burgner; G Eagles; M Burgess; P Procopis; M Rogers; D Muir; R Pritchard; A Hocking; M Priest
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

3.  Ecthyma gangraenosum--a trap for the unwary.

Authors:  G S Arul; R D Spicer
Journal:  Ann R Coll Surg Engl       Date:  2001-01       Impact factor: 1.891

Review 4.  Children hospitalized with skin and soft tissue infections: a guide to antibacterial selection and treatment.

Authors:  Joseph V Vayalumkal; Tajdin Jadavji
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

5.  Surgical strategies in the management of ecthyma gangrenosum in paediatric oncology patients.

Authors:  B A Khalil; C T Baillie; S E Kenny; G L Lamont; R R Turnock; B L Pizer; H F K van Saene; P D Losty
Journal:  Pediatr Surg Int       Date:  2008-04-22       Impact factor: 1.827

6.  Atypical case of ecthyma gangrenosum mimicking a breast cancer recurrence.

Authors:  Emmanuel Seront; François Kidd; Tanguy Metz; Patrick Van Ruyssevelt
Journal:  BMJ Case Rep       Date:  2016-03-30

7.  A single black ulcer in a child with acute lymphocytic leukemia.

Authors:  Michelangelo Vestita; Angela Filoni; Nicola Santoro; Gianpaolo Arcamone; Domenico Bonamonte
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

8.  Non-pseudomonal Ecthyma Gangrenosum and Idiopathic Myelofibrosis in a Two-Year-Old Girl.

Authors:  Muniba Firoz; Ammarah Jamal; Syed Inam Ur Rehman
Journal:  Cureus       Date:  2018-04-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.